Literature DB >> 21228598

Impaired stimulatory effect of ETB receptor on D₃ receptor in immortalized renal proximal tubule cells of spontaneously hypertensive rats.

Ye Zhang1, Chunjiang Fu, Hongmei Ren, Duofen He, Xukai Wang, Laureano D Asico, Pedro A Jose, Chunyu Zeng.   

Abstract

BACKGROUND: Activation of renal D₃ receptor induces natriuresis and diuresis in Wistar-Kyoto (WKY) rats; in the presence of ETB receptor antagonist, the natriuretic effect of D₃ receptor in WKY rats is reduced. We hypothesize that ETB receptor activation may regulate D₃ receptor expression in renal proximal tubule (RPT) cells from WKY rats, which is impaired in RPT cells from spontaneously hypertensive rats (SHRs).
METHODS: D₃ receptor expression was determined by immunoblotting; the D₃/ETB receptor linkage was checked by coimmunoprecipitation; Na(+)-K(+)-ATPase activity was determined as the rate of inorganic phosphate released in the presence or absence of ouabain.
RESULTS: In RPT cells from WKY rats, the ETB receptor agonist BQ3020 increased D₃ receptor protein. In contrast, in RPT cells from SHRs, BQ3020 did not increase D₃ receptor. There was coimmunoprecipitation between D₃ and ETB receptors in RPT cells from WKY and SHRs. Activation of ETB receptor increased D₃/ETB coimmunoprecipitation in RPT cells from WKY rats, but not from SHRs. The basal levels of D₃/ETB receptor coimmunoprecipitation were greater in RPT cells from WKY rats than in those from SHRs. Stimulation of D₃ receptor inhibited Na(+)-K(+)-ATPase activity, which was augmented by the pretreatment with the ETB receptor agonist BQ3020 in WKY RPT cells, but not in SHR RPT cells.
CONCLUSION: ETB receptors regulate and physically interact with D₃ receptors differently in WKY rats and SHRs. The impaired natriuretic effect in SHRs may be, in part, related to impaired ETB and D₃ receptor interactions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228598      PMCID: PMC3031151          DOI: 10.1159/000323135

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  48 in total

1.  Endothelin inhibits fluid and bicarbonate transport in part by reducing Na+/K+ ATPase activity in the rat proximal straight tubule.

Authors:  J Garvin; K Sanders
Journal:  J Am Soc Nephrol       Date:  1991-11       Impact factor: 10.121

2.  Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.

Authors:  L D Asico; C Ladines; S Fuchs; D Accili; R M Carey; C Semeraro; F Pocchiari; R A Felder; G M Eisner; P A Jose
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

3.  Localization of endothelin receptors in rat kidney.

Authors:  M Kohzuki; C I Johnston; S Y Chai; D J Casley; F A Mendelsohn
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

4.  ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.

Authors:  Kazuaki Moridaira; Jeremiah Morrissey; Melanie Fitzgerald; Guangjie Guo; Ruth McCracken; Timothy Tolley; Saulo Klahr
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

5.  Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR.

Authors:  Chunyu Zeng; Laureano D Asico; Xiaoli Wang; Ulrich Hopfer; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2002-12-23       Impact factor: 10.190

6.  Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.

Authors:  D M Pollock; G H Allcock; A Krishnan; B D Dayton; J S Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2000-02

7.  Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells.

Authors:  M L Zeidel; H R Brady; B C Kone; S R Gullans; B M Brenner
Journal:  Am J Physiol       Date:  1989-12

8.  Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells.

Authors:  Rui Pedrosa; Pedro Gomes; Chunyu Zeng; Ulrich Hopfer; Pedro A Jose; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

9.  Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles.

Authors:  Chunyu Zeng; Dan Wang; Zhiwei Yang; Zheng Wang; Lareano D Asico; Christopher S Wilcox; Gilbert M Eisner; William J Welch; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2004-02-09       Impact factor: 10.190

10.  Dopamine D3 receptor mRNA and renal response to D3 receptor activation in spontaneously hypertensive rats.

Authors:  Gerd Luippold; Christine Piesch; Hartmut Osswald; Bernd Mühlbauer
Journal:  Hypertens Res       Date:  2003-10       Impact factor: 3.872

View more
  5 in total

Review 1.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 2.  Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Authors:  Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

3.  Enhanced Natriuresis and Diuresis in Wistar Rats Caused by the Costimulation of Renal Dopamine D3 and Angiotensin II Type 2 Receptors.

Authors:  Sufei Yang; Yu Han; Shuo Zheng; Xun Kou; Laureano D Asico; Hefei Huang; Zhao Gao; Pedro A Jose; Chunyu Zeng
Journal:  Am J Hypertens       Date:  2015-03-13       Impact factor: 2.689

Review 4.  Regulation of sodium transport in the proximal tubule by endothelin.

Authors:  Ye Zhang; Pedro A Jose; Chunyu Zeng
Journal:  Contrib Nephrol       Date:  2011-08-30       Impact factor: 1.580

Review 5.  Endothelin antagonists in hypertension and kidney disease.

Authors:  Kevin E C Meyers; Christine Sethna
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.